Axcelis Technologies (NASDAQ:ACLS – Get Free Report) was downgraded by stock analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research report issued on Saturday, Wall Street Zen reports.
ACLS has been the subject of a number of other reports. Weiss Ratings upgraded shares of Axcelis Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, October 16th. B. Riley Financial reissued a “buy” rating and issued a $140.00 price target (down from $165.00) on shares of Axcelis Technologies in a research note on Friday, November 6th. Craig Hallum upgraded shares of Axcelis Technologies from a “hold” rating to a “buy” rating and set a $140.00 price target on the stock in a research report on Friday, November 6th. Finally, Zacks Research raised shares of Axcelis Technologies from a “hold” rating to a “strong-buy” rating in a research note on Tuesday. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Axcelis Technologies currently has a consensus rating of “Moderate Buy” and a consensus target price of $145.33.
Read Our Latest Research Report on ACLS
Axcelis Technologies Stock Down 9.6%
Axcelis Technologies (NASDAQ:ACLS – Get Free Report) last announced its quarterly earnings data on Thursday, November 5th. The semiconductor company reported $1.26 earnings per share for the quarter, beating analysts’ consensus estimates of $1.11 by $0.15. The company had revenue of $237.78 million for the quarter, compared to analyst estimates of $230.08 million. Axcelis Technologies had a return on equity of 11.51% and a net margin of 11.74%. The firm’s revenue for the quarter was up 11.3% on a year-over-year basis. During the same quarter last year, the firm posted $1.21 EPS. Axcelis Technologies has set its Q4 2026 guidance at 1.500-1.500 EPS. Equities research analysts forecast that Axcelis Technologies will post 3.82 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Axcelis Technologies
Hedge funds have recently modified their holdings of the business. Reinhart Partners LLC. raised its holdings in Axcelis Technologies by 14.2% in the 3rd quarter. Reinhart Partners LLC. now owns 1,060,636 shares of the semiconductor company’s stock valued at $139,134,000 after buying an additional 131,976 shares during the period. Dimensional Fund Advisors LP lifted its position in Axcelis Technologies by 0.4% in the first quarter. Dimensional Fund Advisors LP now owns 844,097 shares of the semiconductor company’s stock valued at $78,565,000 after buying an additional 3,057 shares during the last quarter. Barrow Hanley Mewhinney & Strauss LLC increased its position in shares of Axcelis Technologies by 40.1% during the third quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 549,686 shares of the semiconductor company’s stock valued at $72,108,000 after acquiring an additional 157,446 shares during the last quarter. American Century Companies Inc. boosted its position in shares of Axcelis Technologies by 28.3% during the 3rd quarter. American Century Companies Inc. now owns 474,455 shares of the semiconductor company’s stock worth $62,239,000 after purchasing an additional 104,576 shares during the period. Finally, The Manufacturers Life Insurance Company increased its holdings in Axcelis Technologies by 3,402.5% in the 1st quarter. The Manufacturers Life Insurance Company now owns 491,745 shares of the semiconductor company’s stock valued at $45,772,000 after purchasing an additional 477,705 shares during the last quarter. 89.98% of the stock is currently owned by hedge funds and other institutional investors.
About Axcelis Technologies
Axcelis Technologies develops and manufactures ion implantation equipment used in semiconductor production. Its systems introduce precisely controlled impurities into silicon wafers, helping manufacturers create the electrical properties needed for semiconductor devices. The company’s product lineup includes its Purion family of ion implantation systems. Alongside equipment, Axcelis provides related services such as maintenance, upgrades, spare parts and technical support. Its products and services support semiconductor manufacturing for applications including power devices, which are used in areas such as electric vehicles and energy systems.
Further Reading
- Five stocks we like better than Axcelis Technologies
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
- 3 Dividend ETFs Offering Steadier Footing in a Shaky Market
- Lazard’s New ETF Targets Monthly Income With Junk Bonds
Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
